TAFAZZIN and Barth syndrome: Increased FABP4 expression in TAZ517delG-iPS-CM (Figure 7) suggests that FABP4 plays a role in TAZ-induced cardiac dysfunction, although the exact mechanism of FABP4 in the pathophysiology of Barth syndrome is not established yet.